2-47482910-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000251.3(MSH2):​c.2766T>C​(p.Phe922Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00213 in 1,611,950 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.012 ( 23 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 27 hom. )

Consequence

MSH2
NM_000251.3 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel B:19

Conservation

PhyloP100: 0.382

Publications

8 publications found
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MSH2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 2-47482910-T-C is Benign according to our data. Variant chr2-47482910-T-C is described in ClinVar as Benign. ClinVar VariationId is 91042.Status of the report is reviewed_by_expert_panel, 3 stars.
BP7
Synonymous conserved (PhyloP=0.382 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0115 (1754/152338) while in subpopulation AFR AF = 0.0401 (1668/41570). AF 95% confidence interval is 0.0385. There are 23 homozygotes in GnomAd4. There are 854 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 23 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
NM_000251.3
MANE Select
c.2766T>Cp.Phe922Phe
synonymous
Exon 16 of 16NP_000242.1P43246-1
MSH2
NM_001406638.1
c.2805T>Cp.Phe935Phe
synonymous
Exon 17 of 18NP_001393567.1
MSH2
NM_001406641.1
c.2766T>Cp.Phe922Phe
synonymous
Exon 16 of 17NP_001393570.1P43246-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
ENST00000233146.7
TSL:1 MANE Select
c.2766T>Cp.Phe922Phe
synonymous
Exon 16 of 16ENSP00000233146.2P43246-1
MSH2
ENST00000406134.5
TSL:1
c.2634+2039T>C
intron
N/AENSP00000384199.1E9PHA6
MSH2
ENST00000918107.1
c.2817T>Cp.Phe939Phe
synonymous
Exon 17 of 17ENSP00000588166.1

Frequencies

GnomAD3 genomes
AF:
0.0115
AC:
1748
AN:
152220
Hom.:
23
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0401
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00860
GnomAD2 exomes
AF:
0.00303
AC:
752
AN:
248234
AF XY:
0.00224
show subpopulations
Gnomad AFR exome
AF:
0.0418
Gnomad AMR exome
AF:
0.00202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000711
Gnomad OTH exome
AF:
0.00165
GnomAD4 exome
AF:
0.00115
AC:
1681
AN:
1459612
Hom.:
27
Cov.:
31
AF XY:
0.000960
AC XY:
697
AN XY:
725928
show subpopulations
African (AFR)
AF:
0.0411
AC:
1374
AN:
33396
American (AMR)
AF:
0.00257
AC:
114
AN:
44412
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26068
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39584
South Asian (SAS)
AF:
0.0000584
AC:
5
AN:
85546
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53380
Middle Eastern (MID)
AF:
0.00107
AC:
6
AN:
5626
European-Non Finnish (NFE)
AF:
0.0000369
AC:
41
AN:
1111274
Other (OTH)
AF:
0.00234
AC:
141
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
78
155
233
310
388
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0115
AC:
1754
AN:
152338
Hom.:
23
Cov.:
33
AF XY:
0.0115
AC XY:
854
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0401
AC:
1668
AN:
41570
American (AMR)
AF:
0.00392
AC:
60
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68038
Other (OTH)
AF:
0.00851
AC:
18
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
86
172
258
344
430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00482
Hom.:
14
Bravo
AF:
0.0132
Asia WGS
AF:
0.00144
AC:
5
AN:
3476
EpiCase
AF:
0.0000546
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
4
Lynch syndrome 1 (4)
-
-
2
not provided (2)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)
-
-
1
Lynch syndrome (1)
-
-
1
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
5.6
DANN
Benign
0.77
PhyloP100
0.38
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55859129; hg19: chr2-47710049; API